A turmeric story built around absorption

CurQnetic™ combines turmeric-derived curcumin with vanillin from vanilla and gingerols from ginger. Unibar developed this proprietary formulation to address curcumin’s limited absorption and rapid elimination.

For brands developing botanical wellness products, CurQnetic brings together concentrated curcumin, a distinctive formulation approach, and research on absorption and retention. It offers a clear ingredient story for joint-health and antioxidant-support concepts.*

Benefits & formulation advantages

  • Concentrated ingredient: Unibar lists 95% curcumin, verified by HPLC testing.
  • Absorption-focused formulation: Curcumin is paired with vanillin and gingerols.
  • Botanical wellness positioning: Unibar’s monograph discusses healthy inflammatory response, joint comfort, and antioxidant support.*
  • Supply-chain visibility: Unibar describes farm-to-finished-ingredient traceability and food-grade extraction solvents.

Research & supporting evidence

Animal pharmacokinetics: absorption and retention

Unibar’s bioavailability summary reports a single-dose oral study in Sprague Dawley rats. Compared with standard curcumin, CurQnetic showed up to eightfold oral bioavailability and sixfold longer bloodstream retention, which Unibar associates with its 24-hour bioactivity positioning. These are animal pharmacokinetic findings, not demonstrated 24-hour clinical benefits in people.

Human absorption comparison

The same official summary describes healthy volunteers aged 35–40 receiving a single 2.5 g dose. Reported peak blood concentrations were 94.7 ng/mL for CurQnetic and 55.9 ng/mL for standard curcumin, approximately 70% higher for CurQnetic. This is an absorption endpoint, not a measure of symptom improvement. The summary does not provide participant numbers, statistical detail, or a full protocol; the study dose should not be read as a recommended daily use level.

Preclinical biological activity

Unibar’s efficacy page describes CurQnetic experiments in cell systems and animal models. It reports cytokine inhibition in peripheral blood mononuclear cells and inflammatory-response effects in rats. It also describes colorectal cell-line and mouse-model work on cell proliferation. These findings provide preclinical context and do not establish disease prevention or treatment in humans.

What the broader curcumin literature tells us

The CurQnetic monograph summarizes human research on curcumin for joint comfort, antioxidant status, and other wellness areas. Those studies are background for curcumin; their outcomes should not automatically be attributed to CurQnetic. The monograph identifies its formulation-specific source as an unpublished paper.

Technical specifications & quality

ParameterOfficial supplier information
Botanical sourceTurmeric
Published concentration95% curcumin, HPLC verified
Other formulation componentsVanillin and gingerols
ExtractionFood-grade solvents, including ethyl acetate
Listed certificationsKosher, Parve, Halal
Manufacturing requirements listedISO, cGMP, HAACP, PMDA
Formulation use level & full compositionRequest current CurQnetic specifications and application guidance from Unibar

View the official product information. Confirm grade-specific specifications and certification scope before finalizing a formulation.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.